PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
301 hedge funds and large institutions have $5.24B invested in PRA Health Sciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 98 increasing their positions, 130 reducing their positions, and 75 closing their positions.
117% more call options, than puts
Call options by funds: $8.28M | Put options by funds: $3.81M
13% less funds holding
Funds holding: 345 → 301 (-44)
25% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 130
25% less capital invested
Capital invested by funds: $7.04B → $5.24B (-$1.79B)
53% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 75
83% less funds holding in top 10
Funds holding in top 10: 6 → 1 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$95.9M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$71.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$47.4M |
| 4 |
NIPH
NN Investment Partners Holdings
The Hague,
Netherlands
|
+$26.4M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$16.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
-$28.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$21.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$17.8M |
| 4 |
SO
STRS Ohio
Columbus,
Ohio
|
-$17.3M |
| 5 |
BlackRock
New York
|
-$16.6M |
PRAH Hedge Fund Activity: Q1 2020 in Review
301 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q1 2020, worth a combined $5.24B — down 25% from $7.04B a quarter earlier.
Sellers outnumbered buyers: 75 funds closed out of PRAH and 35 opened new positions — a net loss of 40 holders — while 130 trimmed existing stakes and 98 added.
The largest buyer was Massachusetts Financial Services, adding an estimated $95.9M. The largest seller was Glenview Capital Management, exiting entirely with an estimated $28.1M sold.
- 301 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q1 2020, down from 345 in Q4 2019.
- Funds reported $5.24B of PRA Health Sciences, Inc. stock for Q1 2020, down 25% quarter-over-quarter.
- 35 funds opened new PRA Health Sciences, Inc. positions in Q1 2020 and 75 closed out, a net change of -40 holders.
- The largest PRA Health Sciences, Inc. buyer in Q1 2020 was Massachusetts Financial Services, an estimated $95.9M added.
- The largest PRA Health Sciences, Inc. seller in Q1 2020 was Glenview Capital Management, an estimated $28.1M sold.
Based on aggregated 13F filings for Q1 2020.